Ignite Creation Date:
2024-05-06 @ 1:03 PM
Last Modification Date:
2024-10-26 @ 1:07 PM
Study NCT ID:
NCT03913234
Status:
UNKNOWN
Last Update Posted:
2022-05-10
First Post:
2019-04-10
Brief Title:
Phase IB II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR HER2 Advanced Breast Cancer Patients
Sponsor:
Organization:
Yonsei University